GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (BOM:524404) » Definitions » Market Cap

Marksans Pharma (BOM:524404) Market Cap : ₹100,589 Mil (As of Apr. 02, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Marksans Pharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Marksans Pharma's share price for the quarter that ended in Dec. 2024 was ₹296.7. Marksans Pharma's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 453 Mil. Therefore, Marksans Pharma's market cap for the quarter that ended in Dec. 2024 was ₹134,454 Mil.

Marksans Pharma's quarterly market cap increased from Jun. 2024 (₹71,985 Mil) to Sep. 2024 (₹135,111 Mil) but then declined from Sep. 2024 (₹135,111 Mil) to Dec. 2024 (₹134,454 Mil).

Marksans Pharma's annual market cap increased from Mar. 2022 (₹18,644 Mil) to Mar. 2023 (₹31,487 Mil) and increased from Mar. 2023 (₹31,487 Mil) to Mar. 2024 (₹68,677 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Marksans Pharma's Enterprise Value for Today is ₹95,993 Mil.


Marksans Pharma Market Cap Historical Data

The historical data trend for Marksans Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marksans Pharma Market Cap Chart

Marksans Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,689.46 20,445.23 18,644.25 31,487.11 68,677.00

Marksans Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71,849.93 68,677.00 71,985.10 135,110.85 134,453.76

Competitive Comparison of Marksans Pharma's Market Cap

For the Drug Manufacturers - General subindustry, Marksans Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marksans Pharma's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's Market Cap falls into.


;
;

Marksans Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Marksans Pharma's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹151.55*453.164
=₹68,677

Marksans Pharma's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=₹296.7*453.164
=₹134,454

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marksans Pharma  (BOM:524404) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Marksans Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Marksans Pharma Business Description

Traded in Other Exchanges
Address
Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal, and oncologic drugs as well as antibiotics and antiallergic medications. Geographically, the majority of its revenue is generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, and the Rest of the World.

Marksans Pharma Headlines

No Headlines